Skip to content
RDL
Network
Ekosistem
Uygulama değiştir
EN
Hakkımızda
SSS
Giriş yap
Başla
Shp2 deletion in hepatocytes suppresses hepatocarcinogenesis driven by oncogenic β-Catenin, PIK3CA and MET — Jacey J. Liu (2018) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Shp2 deletion in hepatocytes suppresses hepatocarcinogenesis driven by oncogenic β-Catenin, PIK3CA and MET
Shared by
Michael Karin
University of California, San Diego
Shp2 deletion in hepatocytes suppresses hepatocarcinogenesis driven by oncogenic β-Catenin, PIK3CA and MET
Article
2018
en
Authors
+7 more
JL
Jacey J. Liu
YL
Yanjie Li
WC
Wendy S. Chen
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2009
Short hairpin RNA targeting β-catenin suppresses cell proliferation and induces apoptosis in human gastric carcinoma cells
Hong Jiang
,
Jianguo Xia
,
Jian Jian Kang
,
Y. Ding
,
WU Wen-xi
Article
2024
Abstract 2274: Genomic and transcriptomic analyses of chemical hepatocarcinogenesis aggravated by loss of oncoproteins in hepatocytes
Xinyi Wang
,
Jiemeng Zhang
,
Yingluo Liu
,
Shuo Zhang
,
Yan Liang
,
Min Zong
,
Xiaoxue Lin
,
Michael Karin
,
Gen‐Sheng Feng
Article
2015
NLRP3 inflammasome expression is driven by NF-κB in cultured hepatocytes
Sorina Georgiana Boaru
,
Erawan Borkham‐Kamphorst
,
Eddy Van de Leur
,
Eric Lehnen
,
Christian Liedtke
,
Ralf Weiskirchen
Article
2017
Syndecan-1 promotes Wnt/β-catenin signaling in multiple myeloma by presenting Wnts and R-spondins
Zemin Ren
,
Harmen van Andel
,
Wim de Lau
,
Robin B. Hartholt
,
Madelon M. Maurice
,
Hans Clevers
,
Marie José Kersten
,
Marcel Spaargaren
,
Steven T. Pals
Corrigendum
2025
Author Correction: HDAC1 and HDAC2 regulate oligodendrocyte differentiation by disrupting the β-catenin–TCF interaction
Feng Ye
,
Ying Chen
,
ThaoNguyen Hoang
,
Rusty L. Montgomery
,
Xian-hui Zhao
,
Hong Bu
,
Tom C. Hu
,
Makoto M. Taketo
,
Johan H. van Es
,
Hans Clevers
,
Jenny Hsieh
,
Rhonda Bassel‐Duby
,
Eric N. Olson
,
Q. Richard Lu
Discussion(0)
No comments yet. Be the first to comment.